Session

Biomarkers
Digital Poster
Clinical
Performance and Clinical Utility of Next Generation Sequencing in Head and Neck Cancer and Thyroid Cancer Pathways
Ian Sann Boon, United Kingdom
E25-10
Can pre-radiotherapy systemic immune-inflammation index predict prognosis in thymic epithelial tumors?
Alper Kahvecioglu, Turkey
E25-2498
The influence of radiotherapy on cellular senescence
Katarzyna Paal, Austria
E25-4496
Immunological inflammatory biomarkers can serve as prognostic predictors for liver mCRC patients undergoing SBRT treatment.
Kiril Zhelev, Bulgaria
E25-27
Circulating tumor DNA as a comprehensive recurrence risk biomarker after ablative radiotherapy for early-stage non-small cell lung cancer
Masaki Nakamura, Japan
E25-60
Correlation between pre-treatment PSMA-PET and early PSA response in MR-guided SBRT with intraprostatic lesion boost for prostate cancer
Darren MC Poon, China, Hong Kong Special Administrative Region
E25-463
screening of clinical nutritional indicators influencing radiation enteritis associated with TNT in LARC
Chenying Ma, China
E25-1293
The role of proteomics in predicting the risk of radiation necrosis following SRS treatment for brain metastases
Paola Jablonska, Spain
E25-2305